Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C
about
Prediction of liver cirrhosis, using diagnostic imaging tools.The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic reviewHepatic steatosis and fibrosis: Non-invasive assessment.Usefulness of Contrast-Enhanced Ultrasonography for Predicting Esophageal Varices in Patients with Hepatitis B Virus (HBV)-Related Cirrhosis.Washout Ratio in the Hepatic Vein Measured by Contrast-Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs.Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.Ultrasound in chronic liver disease.Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography.Invasive and non-invasive diagnosis of cirrhosis and portal hypertensionDiagnosis of liver cirrhosis with contrast-enhanced ultrasoundNoninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.Assessing liver fibrosis.Contrast-enhanced ultrasonography of the hepatic vein in normal dogs.Recent advances in imaging hepatic fibrosis and steatosis.Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.Treatment of hepatitis C virus infection in intravenous drug users.Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-AnalysisEvaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.Non-biopsy methods to determine hepatic fibrosis.Transient elastography for the assessment of chronic liver disease: ready for the clinic?Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver diseaseNon-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques.Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C.Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study.Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion.Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study.Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance.Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein.
P2860
Q26795413-18520433-180C-4203-9F8A-A2D55F7DDBF6Q26996085-B8C820EB-FD33-43F7-9D73-E894A47E07EBQ28077200-AA24049D-65BE-4052-BA4D-35DAA09EF87BQ30355615-B02AC999-B4F6-4A3E-9F5A-71FF84099A09Q30356064-F87D6974-2BB0-409D-A4AC-55FF47B86836Q30398077-A0C014C9-C797-4701-9854-94DCBB7719D7Q30412771-1B84366D-3C70-44F1-ABB9-7AF239893613Q30414993-1F68A6DB-A1B2-4286-9E9C-A58F08F11858Q30432218-76B4773A-6265-4F36-9F78-C47AF8ADE107Q30433926-49EBAE67-D5B5-45F4-8E6F-E9B5BF9CAEF2Q30434570-06B9F4A3-7492-4EE6-9471-84793BB57716Q30439743-54F8C591-F077-4AD9-BA0A-25B5EB4DDA2EQ30478158-6C4AA2C7-D6FC-4969-A7DA-C188AD404BADQ30479092-8C2DAA06-0F2E-4DF4-B799-978C604F6AA0Q33866965-61026848-394D-4C7E-A94F-0FA8D831C59AQ34658635-7DF50E11-7320-4926-880D-4F0812A076E5Q35472862-2B7F5993-49D7-463E-8C89-6F84556ACFDAQ35769146-87DE39B7-A05A-4C63-AF4C-B14B9FC0DA61Q37345958-E3623B6C-BBC9-4377-B312-12BC0B4D0E2FQ37590037-3CB401BF-56DF-4C5A-80C6-FB3B5AC5FCE6Q37839093-61F3A35E-DA1B-48C2-8DE9-649A0060A068Q37897194-BC72E1F1-D862-4C0C-B258-53053A50A608Q37995326-4751352B-A898-4A4B-A51B-90E45BE0ABE5Q38779490-B21F5C5B-8D3F-4FA2-BF11-92B05A5A0399Q38931032-C8D8B090-FE8F-4DFC-BA17-A78EE67607AEQ39380465-D62E4246-9901-47B4-BDE6-5335561F1014Q39826805-B29CE249-0D10-4A24-85EF-4E383705C888Q42160967-1C7D4C26-21E0-4EBD-BB21-D160F9A84970Q42593971-F715129B-E775-414C-923D-F5412D453127Q42726001-216D4DA3-5889-4ADA-9990-6FC99CA4ED31Q42835985-0754F5B7-FE84-4CD7-9F37-BC360E87502EQ46793741-4067542E-AA83-4373-9E01-55F270EC17CAQ47802250-B00C87B6-2499-49B5-9706-4C56D88D9E1BQ47810197-2CF23A47-4FD7-4373-A53F-921B4803B12FQ48032581-4FFF8AC0-E81C-434E-88E8-B64ADBF4621CQ48119594-2959FF3A-0B3D-4BE8-A8BC-F6F9760DC10DQ50199685-22950490-6E68-4BC7-B5C2-0DEEA71E8188Q50224570-3F2B4842-9A94-45FE-AAEA-697F69FEF5DEQ50244030-A3A473FF-18BA-44B4-BFB5-C2FB7FFAC975Q50481494-794B4E8D-3A59-40C1-9F4C-139A1F5BE74A
P2860
Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatic vein transit times usi ...... y in patients with hepatitis C
@ast
Hepatic vein transit times usi ...... y in patients with hepatitis C
@en
type
label
Hepatic vein transit times usi ...... y in patients with hepatitis C
@ast
Hepatic vein transit times usi ...... y in patients with hepatitis C
@en
prefLabel
Hepatic vein transit times usi ...... y in patients with hepatitis C
@ast
Hepatic vein transit times usi ...... y in patients with hepatitis C
@en
P2093
P2860
P356
P1433
P1476
Hepatic vein transit times usi ...... y in patients with hepatitis C
@en
P2093
D O Cosgrove
G R Foster
H C Thomas
M J K Blomley
R D Goldin
S D Taylor-Robinson
P2860
P304
P356
10.1136/GUT.2003.030965
P407
P577
2005-01-01T00:00:00Z